Mike is the head of UK NSC transparency and public understanding. A former journalist, he has worked in screening since 2010.
The UK NSC’s 2024 annual call for new screening topics has opened, giving stakeholders the chance to propose potential new screening programmes, new technologies we have not previously reviewed, modifications to current screening programmes, or early updates to topics the committee has considered recently.
Greg Fell brings public health passion and expertise to key role on the UK NSC.
UK NSC's clinical ethicist members has tandem passions in work and leisure.
Dr Graham Shortland OBE talks about his roles on the UK NSC as vice-chair and a paediatric specialist and the exciting challenges facing the committee.
Anneke helps the UK NSC navigate the complexities of clinical genetics evidence in screening when public expectations about the ability of genetics to predict ill health are running high.
The English government has endorsed the UK National Screening Committee’s recommendation to add hereditary tyrosinaemia type 1 to the conditions screened for by the NHS Newborn Blood Spot Screening Programme.
Important factors, roles and responsibilities to consider for anyone wanting to conduct research or evaluation into screening.
The UK NSC is consulting on whether to add the quadruple test to the antenatal screening pathway for Edwards' syndrome.
The UK National Screening Committee held a horizon scanning event in Edinburgh to explore potential developments in research, international policy making and emerging technologies related to bowel cancer screening.
We have published updated information on paid-for commercial screening tests and how they differ from quality-assured end-to-end NHS screening programmes